The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 2909730 |
10 |
Flavones. 2. Synthesis and structure-activity relationship of flavodilol and its analogues, a novel class of antihypertensive agents with catecholamine depleting properties. |
Pennwalt |
| 2887658 |
5 |
Carbostyril derivatives having potent beta-adrenergic agonist properties. |
TBA |
| 2883317 |
6 |
Flavones. 1. Synthesis and antihypertensive activity of (3-phenylflavonoxy)propanolamines without beta-adrenoceptor antagonism. |
TBA |
| 2882025 |
20 |
Affinity labels for beta-adrenoceptors: preparation and properties of alkylating beta-blockers derived from indole. |
TBA |
| 2866247 |
20 |
Alkylating beta-blockers: activity of isomeric bromoacetyl alprenolol menthanes. |
TBA |
| 6124637 |
18 |
Syntheses and adrenergic agonist properties of ring-fluorinated isoproterenols. |
TBA |
| 7328588 |
9 |
Synthesis and adrenoceptor affinity of some highly polar beta-substituted catecholamines. |
TBA |
| 6120233 |
43 |
beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines. |
TBA |
| 6248642 |
38 |
Mammalian alkaloids. 8. Synthesis and biological effects of tetrahydropapaveroline related 1-benzyltetrahydroisoquinolines. |
TBA |
| 26709102 |
142 |
Discovery of Vibegron: A Potent and Selectiveß3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. |
Merck Research Laboratories |
| 26125514 |
40 |
Discovery of Novel Indazole Derivatives as Highly Potent and Selective Humanß3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects. |
Asahi Kasei Pharma |
| 11311067 |
38 |
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence. |
Kissei Pharmaceutical |
| 24900353 |
6 |
Combination of a Beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity. |
TBA |
| 7562902 |
114 |
Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. |
Smithkline Beecham Pharmaceuticals |
| 8254623 |
54 |
Syntheses of 2,5- and 2,6-difluoronorepinephrine, 2,5-difluoroepinephrine, and 2,6-difluorophenylephrine: effect of disubstitution with fluorine on adrenergic activity. |
National Institute of Diabetes and Digestive and Kidney Diseases |
| 1573641 |
60 |
SC-53116: the first selective agonist at the newly identified serotonin 5-HT4 receptor subtype. |
Searle Research and Development |
| 1361578 |
99 |
Synthesis and biological characterization of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents. |
Bristol-Myers Squibb |
| 2539480 |
50 |
Design and synthesis of propranolol analogues as serotonergic agents. |
Virginia Commonwealth University |
| 2845082 |
35 |
Syntheses and adrenergic activities of ring-fluorinated epinephrines. |
National Institute of Diabetes |
| 6134833 |
91 |
Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans. |
TBA |
| 20812727 |
157 |
Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography. |
National Institute of Mental Health |
| | 7 |
SYNTHESIS AND BIOLOGICAL EVALUATION OF A FLUORINATED ANALOG OF THE β-ADRENERGIC BLOCKING AGENT, METOPROLOL |
TBA |
| | 3 |
Asymmetric synthesis of FR165914: A novel β3-adrenergic agonist with a benzocycloheptene structure |
TBA |
| 17911024 |
37 |
Potent oxindole based human beta3 adrenergic receptor agonists. |
Eli Lilly |
| 17632003 |
55 |
Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity. |
Pfizer |
| 16931005 |
21 |
Potent benzimidazolone based human beta(3)-adrenergic receptor agonists. |
Eli Lilly |
| 8496920 |
14 |
(S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. |
Wyeth Research (Uk) |
| 8411007 |
392 |
Chemistry, binding affinities, and behavioral properties of a new class of"antineophobic" mitochondrial DBI receptor complex (mDRC) ligands. |
Mayo Foundation |
| 8410999 |
81 |
3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity. |
Eli Lilly |
| 31485 |
8 |
Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols. |
TBA |
| 231654 |
16 |
Synthesis and biological properties of 2-, 5-, and 6-fluoronorepinephrines. |
TBA |
| 8246239 |
84 |
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives. |
Solvay Duphar |
| 9240350 |
9 |
A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists. |
Monash University |
| 3746815 |
15 |
In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin. |
TBA |
| 1672155 |
14 |
Effect of fluorine substitution on the adrenergic properties of 3-(tert-butylamino)-1-(3,4-dihydroxyphenoxy)-2-propanol. |
National Institute of Diabetes |
| 1652026 |
43 |
Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity. |
Virginia Commonwealth University |
| 1354264 |
19 |
Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent. |
American Cyanamid |
Search and Browse
